Metabolic effects and myocardial activity of heparin. Experimental research
Rognoni, F.; Piacenza, G.
Bollettino Della Societa Italiana di Cardiologia 20(12): 1693-1698
1975
ISSN/ISBN: 0037-878X PMID: 1234467 Document Number: 87071
Document emailed within 1 workday
Related Documents
Kaiser, B.; Hauptmann, J.; Markwardt, F. 1988: Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative Folia Haematologica 115(1-2): 119-125Aniukhovskiĭ, E.P.; Ivanovich, T.; Beloshapko, G.G.; Rozenshtraukh, L.V. 1989: Effects of tetrodotoxin and verapamil on abnormal ventricular activity at the late stage of experimental myocardial infarction in dogs Kardiologiia 29(5): 66-71
Chander, C.L.; Colville-Nash, P.R.; Moore, A.R.; Howat, D.W.; Desa, F.M.; Willoughby, D.A. 1989: The effects of heparin and cortisone on an experimental model of pannus International Journal of Tissue Reactions 11(3): 113-116
Zoloev, G.K.; Slepushkin, V.D.; Titov, M.I. 1985: Effect of enkephalins on metabolic indices in experimental myocardial infarct in rats Kardiologiia 25(8): 72-74
Balta, N.; Dumitriu, I.F.; Stoian, G.; Filcescu, V.; Petec, G.; Dinischiotu, A.; Dragulescu, N. 1995: Research on some metabolic and enzymatic modifications in experimental hypertensive myocardium Romanian Journal of Physiology 32(1-4): 45-58
Tschirkov, F.; Greifenstein, J.; Eisenbach, J.; Röttger, P.; Heine, H. 1972: Experimental myocardial infarct. Preliminary report. 1. Hemodynamics, electrolytes in the myocardial tissue and coronary vein, blood morphology. Effects of Trasylol Die Medizinische Welt 23(49): 1838-1843
Iakushev, V.S.; Lifshits, R.I.; Slobodin, V.B.; Efimenko, G.P. 1974: Radioisotope indication of metabolic processes in the myocardium and liver during the acute period of experimental myocardial ischemia Kardiologiia 15(3): 35-39
Seed, M.; Houston, S. 1976: The pill and its effects--metabolic research at St Mary's Nursing Times 72(13): 509-511
Heine, H. 1983: Transcutaneous heparin therapy. Experimental histological studies with the effective combination heparin--allantoin--D panthenol Die Medizinische Welt 34(20): 602-604
Tian, Y.-f.; Wang, R.; Li, L.-y.; Wang, J.; Jin, C.-n.; Hao, C.-y. 2007: Effects of acupuncture at the points of the Pericardium Meridian on the activity of myocardial Ca2+-ATPase and gene expression in the rat of myocardial ischemia and reperfusion injury Zhongguo Zhen Jiu 27(3): 205-208
Hackett, A.M.; Griffiths, L.A. 1983: The effects of an experimental hepatitis on the metabolic disposition of 3-o-(+)-[14C]methylcatechin in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 11(6): 602-606
Balazs, T. 1976: Pathophysiologic significance of endocrine or metabolic effects of DDT in experimental animals Federation Proceedings 35(14): 2609
Suemori, I. 1976: Experimental study on dibutyryl cyclic amp. part 1. Metabolic effects in man Masui. Japanese Journal of Anesthesiology 25(5): 457-464
Sampol, J.; Rossi, J.M.; Lejay, G. 1984: Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex Annales de Biologie Clinique 42(1): 21-23
Carrier, M.; Khalil, A.; Tourigny, A.; Solymoss, B.C.; Pelletier, L.C. 1996: Metabolic recovery after global myocardial ischemia: effects of blood cardioplegic solutions Canadian Journal of Cardiology 12(6): 607-611
Sysoeva, N.A.; Oganov, R.G.; Mikhaĭlova, I.L. 1982: Metabolic effects of a glucose-insulin-potassium mixture in acute myocardial infarct Kardiologiia 22(10): 77-82
Kline, J.A.; Leonova, E.; Raymond, R.M. 1995: Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine Critical Care Medicine 23(7): 1251-1263
Jacobs, C.; Grebe, S.; Kietzmann, M.; Mischke, R. 1999: Pharmacokinetics of an unfractionated heparin (Liquemin) in the dog after intravenous and subcutaneous application based on heparin activity Deutsche Tierärztliche Wochenschrift 106(11): 478-481
Dragani, L.; Colozzi, A.; Schiavone, C.; Obletter, G.; Celiberti, V.; Radico, S.; Vecchiet, L. 1989: A heparin-glucuronylglucosaminoglycan combination for topical use. An evaluation of the therapeutic effects in induced experimental muscle damage and in minor sports injuries Minerva Medica 80(4): 397-403
Gilman, S.; Dauth, G.W.; Frey, K.A.; Aldridge, J.W.; Penney, J.B. 1984: Basal ganglia glucose metabolic and single neural unit activity in experimental hemiplegia International Journal of Neurology 18: 79-93